4QV-15215-47053
2 vaccinations
2 coded responses
18 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 773 / TX
- Registered
- 2021-06-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-20
Dose 1 — Pfizer-BioNTech
-
2021-06-21
Registered in v-safe
-
2021-06-21
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Chills, Muscle or body aches, Diarrhea, Abdominal painAdult check-in
- 2021-06-23
- 2021-06-24
- 2021-06-27
- 2021-07-04
-
2021-07-11
Dose 2 — Pfizer-BioNTech
-
2021-07-11
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-07-12
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-07-14
- 2021-07-16
- 2021-07-17
- 2021-07-18
- 2021-07-27
- 2021-08-03
- 2021-08-08
- 2021-08-16
- 2021-08-24
-
2021-10-12
Survey response — 3 months, dose 2MedDRA: Hypertension, Pre-existing disease — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Postpartum preeclampsia/high blood pressureMedDRA releases: 2024-11 · check-in free text available
-
2021-10-12
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2021-10-13
-
2022-01-13
Survey response — 6 months, dose 2MedDRA: Pyrexia — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Fever from Moderna booster yesterdayMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-20 | Pfizer-BioNTech | No |
| 2 | 2021-07-11 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-12 | Unsuccessful |
Free text
Release 10 — 3 months, dose 2
Symptoms: Postpartum preeclampsia/high blood pressure
Release 10 — 6 months, dose 2
Symptoms: Fever from Moderna booster yesterday
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hypertension | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release